Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_assertion type Assertion NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_head.
- NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_assertion description "[Subtle differences in the effects of these different mutations on the many activities of TFIIH and on its stability determine the clinical outcomes, which can be XP, TTD, XP with CS, XP with TTD or COFS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_provenance.
- NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_assertion evidence source_evidence_literature NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_provenance.
- NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_assertion SIO_000772 14726016 NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_provenance.
- NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_assertion wasDerivedFrom befree-2016 NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_provenance.
- NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_assertion wasGeneratedBy ECO_0000203 NP428136.RAprPL5yMGaMDtB9Cr0Bo4vR8ljboTqBC-n97qRoJctHM130_provenance.